Severity of rotavirus gastroenteritis in an Indian population: report from a 3 year surveillance study

Ann Mathew1, P S Sundar Rao2, Thuppal V Sowmyanarayanan3

  • 1Department of Pediatrics, St. Stephens' Hospital, Delhi, India.

Vaccine
|August 6, 2014
PubMed

Insights

Rotavirus gastroenteritis (RVGE) is severe in infants under six months. This study found younger infants experienced worse outcomes, highlighting the need for early rotavirus immunization.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Rotavirus gastroenteritis (RVGE) is a leading cause of severe diarrheal disease in infants and young children globally.
  • Hospitalization data is crucial for understanding the burden of severe RVGE in vulnerable populations.

Purpose of the Study:

  • To investigate the severity of rotavirus gastroenteritis (RVGE) in hospitalized children under 60 months of age.
  • To compare RVGE severity in infants aged 0-5 months versus children aged 6-23 months.

Main Methods:

  • A 3-year surveillance study was conducted.
  • Data collected included RVGE hospitalizations and clinical severity indicators.
  • Comparison of disease severity between infants (0-5 months) and older children (6-23 months).

Main Results:

  • An early peak of rotavirus disease was observed, with 31% of RVGE hospitalizations occurring in infants under 6 months.
  • Infants aged 0-5 months exhibited higher incidences of severe dehydration, acidemia, and acidosis upon admission.
  • Younger infants also experienced prolonged hospitalizations exceeding 7 days.

Conclusions:

  • Infants in the first five months of life are particularly vulnerable to severe rotavirus gastroenteritis.
  • Findings support the need for timely rotavirus immunization, potentially including an accelerated schedule or a birth dose.
  • Early vaccination is critical to protect this high-risk age group from severe RVGE outcomes.

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
83
Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
140
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.9K
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
27
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
851
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.6K